Australia markets closed

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.74+0.71 (+2.63%)
At close: 04:00PM EDT
26.81 -0.93 (-3.35%)
Pre-market: 08:00AM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-643,202
-643,202
-481,183
-562,539
-448,724
Depreciation & amortisation
6,494
6,494
6,771
5,843
1,456
Stock-based compensation
108,710
108,710
91,559
99,505
58,459
Change in working capital
5,057
5,057
28,079
-4,396
14,934
Accounts payable
2,780
2,780
-349
2,833
-735
Other working capital
-529,026
-529,026
-425,815
-546,180
-407,232
Other non-cash items
23,327
23,327
-90,025
18,498
32,791
Net cash provided by operating activities
-527,720
-527,720
-419,494
-497,934
-399,714
Cash flows from investing activities
Investments in property, plant and equipment
-1,306
-1,306
-6,321
-48,246
-7,518
Acquisitions, net
-
-
-
-
0
Purchases of investments
-137,264
-137,264
-193,055
-643,275
-287,852
Sales/maturities of investments
193,106
193,106
532,523
477,041
249,137
Other investing activities
-503
-503
120,000
13,654
-6,760
Net cash used for investing activities
54,033
54,033
453,147
-200,826
-52,993
Cash flows from financing activities
Debt repayment
0
0
-20,486
-124,119
0
Common stock issued
449,810
449,810
4,852
0
0
Common stock repurchased
-6,880
-6,880
-1,561
-204,746
-75,714
Dividends paid
-
-
-
-
0
Other financing activities
-801
-801
837
-97,654
8,055
Net cash used provided by (used for) financing activities
451,535
451,535
-13,134
736,446
447,189
Net change in cash
-22,152
-22,152
20,519
37,686
-5,518
Cash at beginning of period
416,884
416,884
396,365
358,679
364,197
Cash at end of period
394,732
394,732
416,884
396,365
358,679
Free cash flow
Operating cash flow
-527,720
-527,720
-419,494
-497,934
-399,714
Capital expenditure
-1,306
-1,306
-6,321
-48,246
-7,518
Free cash flow
-529,026
-529,026
-425,815
-546,180
-407,232